Compare KALA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALA | TOMZ |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 13.2M |
| IPO Year | 2017 | 2009 |
| Metric | KALA | TOMZ |
|---|---|---|
| Price | $0.53 | $1.46 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 364.1K | 10.5K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.39 | 13.64 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,635,927.00 |
| Revenue This Year | N/A | $48.56 |
| Revenue Next Year | N/A | $121.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.50 |
| 52 Week High | $19.77 | $2.12 |
| Indicator | KALA | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.00 | 39.88 |
| Support Level | $0.51 | $0.68 |
| Resistance Level | $0.72 | $1.95 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 18.67 | 3.45 |
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.